Patents by Inventor Ying Lv

Ying Lv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino acid derivative containing non-steroidal anti-inflammatory drug structure and preparation method and application thereof
    Patent number: 12552747
    Abstract: The present invention discloses an amino acid derivative containing a non-steroidal anti-inflammatory drug structure and a preparation method and application thereof. The structural formula of the derivative is as represented by formula I. The novel compound has a broad-spectrum anti-tumor effect, can prolong the survival period of tumor patients, and improve the quality of life of tumor patients.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: February 17, 2026
    Assignee: JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD.
    Inventors: Yuxin Chen, Mingxia Chen, Ying Lv, Gang Dong, Xiaoxue Huang
  • AMINO ACID DERIVATIVE CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG STRUCTURE AND PREPARATION METHOD AND APPLICATION THEREOF
    Publication number: 20230167059
    Abstract: The present invention discloses an amino acid derivative containing a non-steroidal anti-inflammatory drug structure and a preparation method and application thereof. The structural formula of the derivative is as represented by formula I. The novel compound has a broad-spectrum anti-tumor effect, can prolong the survival period of tumor patients, and improve the quality of life of tumor patients.
    Type: Application
    Filed: May 7, 2021
    Publication date: June 1, 2023
    Inventors: Yuxin CHEN, Mingxia CHEN, Ying LV, Gang DOGN, Xiaoxue HUANG
  • Antidiabetic substituted heteroaryl compounds
    Patent number: 9834563
    Abstract: The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof. The compounds of formula I are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: December 5, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: William K. Hagmann, Bing Li, Jason W. Szewczyk, Bowei Wang, Dann Parker, Timothy Blizzard, Hubert Josien, Purakkattle Biju, Harry Chobanian, Candido Gude, Ravi P. Nargund, Barbara Pio, Qun Dang, Linus S. Lin, Bin Hu, Mingxiang Cui, Zhengxia Chen, Meibi Dai, Zaihong Zhang, Ying Lv, Lili Tian
  • ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS
    Publication number: 20170166578
    Abstract: The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof. The compounds of formula I are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 15, 2017
    Inventors: William K. Hagmann, Bing Li, Jason W. Szewczyk, Bowei Wang, Dann Parker, Timothy Blizzard, Hubert Josien, Purakkattle Biju, Harry Chobanian, Candido Gude, Ravi P. Nargund, Barbara Pio, Qun Dang, Linus S. Lin, Bin Hu, Mingxiang Cui, Zhengxia Chen, Meibi Dai, Zaihong Zhang, Ying Lv, Lili Tian
  • Kiwifruit plant named 'Yang's Golden Red No. 1'
    Publication number: 20170079172
    Abstract: A kiwifruit plant particularly distinguished by cylindrical fruit shape with a concave stylar end, pale yellow fruit flesh with red color radiating from the axial ovary, early fruit maturity and an average fruit weight of 90 to 94 grams is described.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 16, 2017
    Inventors: Shengmou Yang, Xiaoqin Jiang, Ying Lv, Jian Yang
  • Kiwifruit plant named 'Yang's Golden Red No. 50'
    Publication number: 20150342100
    Abstract: A kiwifruit plant particularly distinguished by pale yellow fruit flesh with red color radiating from the axial ovary, cylindrical fruit shape with a circular cross section and slightly blunt protruding stylar end, mid-season fruit maturity and an average fruit weight of 104 grams is described.
    Type: Application
    Filed: May 23, 2014
    Publication date: November 26, 2015
    Inventors: Shengmou Yang, Xiaoqin Jiang, Ying Lv, Jian Yang
  • Kiwifruit plant named ‘Yang's Golden Red No. 50’
    Patent number: PP26450
    Abstract: A kiwifruit plant particularly distinguished by pale yellow fruit flesh with red color radiating from the axial ovary, cylindrical fruit shape with a circular cross section and slightly blunt protruding stylar end, mid-season fruit maturity and an average fruit weight of 104 grams is described.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: March 8, 2016
    Inventors: Shengmou Yang, Xiaoqin Jiang, Ying Lv, Jian Yang
  • Kiwifruit plant named ‘Yang's Golden Red No. 1’
    Patent number: PP28580
    Abstract: A kiwifruit plant particularly distinguished by cylindrical fruit shape with a concave stylar end, pale yellow fruit flesh with red color radiating from the axial ovary, early fruit maturity and an average fruit weight of 90 to 94 grams is described.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: October 31, 2017
    Inventors: Shengmou Yang, Xiaoqin Jiang, Ying Lv, Jian Yang